glp-1 news today 2025 november Drugs: Pulse Survey (U.S.) Trump administration secures deal to

4, 2023, pp

Suspected adverse reactions can be reported through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)

It may be that short-acting GLP-1RAs act more like endogenous GLP-1 and communicate to the brain primarily via the vagus nerve, whereas long-acting GLP-1RAs like liraglutide and semaglutide primarily access the brain directly

Mechanistically, GLP1R is expressed at low levels in the heart and vasculature, raising the possibility that GLP1 might have both direct and indirect actions on the cardiovascular system

The lawsuit accuses manufacturer Novo Nordisk of failing to warn patients and healthcare providers of the potential risk of vision loss